Top 20 Companies in the Global Iron-Deficiency Anemia Treatment Market (2025-2035): Expert View by Spherical Insights

Description

According to a research report published by Spherical Insights & Consulting, The Global Iron-Deficiency Anemia Treatment Market Size Is Projected To Grow From USD 5.47 Billion In 2024 To USD 11.37 Billion By 2035, At A CAGR Of 6.9% During The Forecast Period 2025–2035. Global market expansion is fuelled by rising prevalence of iron-deficiency anemia (especially among women and children), growing awareness and screening programs, improving access to healthcare, and rising adoption of advanced therapies.

 

Introduction

The global iron deficiency anemia treatment market is experiencing growth because three different types of factors combine to drive its expansion. Market demand is increasing because more women of reproductive age, pregnant women, and children are developing iron deficiency anemia through their inadequate nutrient intake and their malnutrition, their high pregnancy rates, and their chronic gastrointestinal diseases, which disrupt iron metabolism. Currently, 30.7% of women aged 15 to 49 years worldwide face anaemia while this study shows that 35.5% of pregnant women and 30.5% of non-pregnant women within this age group experience the same condition in 2023. In addition, the rising awareness of the burden of anemia, which is a critical public health issue, is driving the launch of several anemia-related screening programs, which are being undertaken in association with the government and other global health authorities, thereby creating a high treatment rate, particularly in the emerging markets. Finally, the rising treatment options are playing an equally important role in the growth of the global iron deficiency anemia treatment market, particularly due to the rising acceptance of intravenous iron products, which are witnessing high demand due to the ability of these products to provide efficient treatment, particularly in moderate to severe anemia cases, in comparison to oral iron supplements, which are often associated with low patient compliance.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights— Download the Brochure now and dive deeper into the future of the Global Iron-Deficiency Anemia Treatment Market

 

 Iron-Deficiency Anemia Treatment Market Size & Statistics

• The Market Size for Iron-Deficiency Anemia Treatment Was Estimated to be worth USD 5.47 Billion in 2024.
• The Market Size is Going to Expand at a CAGR of 6.9% between 2025 and 2035.
• The Global Iron-Deficiency Anemia Treatment Market Size is anticipated to reach USD 11.37 Billion by 2035.
• North America is estimated to dominate the market during the forecast period in the Iron-Deficiency Anemia Treatment Market.
• Asia-Pacific is projected to grow the fastest during the forecast period in the Iron-Deficiency Anemia Treatment Market.

 

Market Segmentation

Global Iron-Deficiency Anemia Treatment Market Size, Share, By Drug Type (Ferrous Sulfate, Ferrous Gluconate, Ferrous Fumarate, Ferric Hydroxide, and Others), By Dosage Form (Tablets, Capsules, and Liquid), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.

 

Regional growth and demand

North America is expected to dominate the market during the forecast period in the iron-deficiency anemia treatment market.

North America held the majority of the market share by revenue for the iron-deficiency anemia treatment market. The region benefits from its established healthcare system because people understand medical information, and they can access modern diagnostic tools and treatment methods. The area receives advantages through its solid reimbursement frameworks, high level of diagnostic accuracy, and major pharmaceutical firms provide various oral and intravenous iron treatment options.

 

Asia-Pacific is projected to grow the fastest during the forecast period in the iron-deficiency anemia treatment market.

Asia-Pacific is projected to grow the fastest during the forecast period in the iron-deficiency anemia treatment market. The combination of large patient populations and high rates of nutritional deficiencies, together with improved healthcare access in India and China. The market is experiencing growth because of three factors, which include government health programs, increased healthcare funding, and a better understanding of the benefits of early disease detection and treatment. The WHO analysis from 2025 shows that anaemia still represents a significant public health issue in South Asia because it affects most adolescent girls and women who live there. The authorities need to take immediate measures which will stop 18 million people from developing anaemia by the year 2030.The regional market expansion is being driven by two factors, which include the development of pharmaceutical production facilities and the growing use of cutting-edge medical treatments.

 

 

Top 10 Trends in the Iron-Deficiency Anemia Treatment Market

• Rising Adoption of Intravenous (IV) Iron Therapies for Faster and More Effective Treatment
• Increasing Demand for Oral Iron Supplements Due To Convenience and Cost-Effectiveness
• Growing Focus on Early Diagnosis and Screening Programs
• Emergence Of Advanced Formulations, Including Nanomedicine-Based Therapies
• Expansion Of Iron-Fortified Foods and Functional Nutrition Products
• Rising Prevalence of Chronic Diseases Linked to Anemia (E.G., CKD, Cancer)
• Increasing Government Initiatives and Public Health Programs to Reduce Anemia Burden
• Growing Preference for Personalized and Targeted Treatment Approaches
• Expanding Pharmaceutical R&D And New Product Launches
• Improving Healthcare Access and Infrastructure in Emerging Economies

 

Unlock exclusive market insights— Download the Brochure now and dive deeper into the future of the Global Iron-Deficiency Anemia Treatment Market

1.Rising adoption of intravenous (IV) iron therapies for faster and more effective treatment

The treatment, which uses intravenous iron, delivers rapid results because it restores iron levels to patients who suffer from severe anemia and who cannot use oral iron supplements. The treatment provides enhanced results that patients can better follow when they receive treatment inside a medical facility.

 

2.Increasing demand for oral iron supplements due to convenience and cost-effectiveness

The demand for oral iron supplements has increased because patients with mild to moderate anemia prefer this treatment, which offers affordable pricing, convenient availability, and straightforward application. The company makes ongoing product advancements that decrease gastrointestinal side effects while enhancing patient adherence to treatment.

 

3.Growing focus on early diagnosis and screening programs

Screening programs for anemia patients experience increased attention because healthcare workers need to identify individuals who face heightened risks of developing the disease. The system helps clients receive better treatment because it increases the number of patients who access care at their earliest point of need.

 

4.Emergence of advanced formulations, including nanomedicine-based therapies

The medical field concentrates on developing new drug formulations, which include nanomedicine as a treatment method. The advanced system of drug delivery uses nanotechnology to enhance treatment effectiveness while minimizing harmful effects for patients who have anemia.

 

5.Expansion of iron-fortified foods and functional nutrition products

The rising presence of iron-fortified food products and drinks in the market helps to solve nutritional deficiencies that affect entire populations. The preventive method decreases anemia cases while supporting existing medical treatment approaches.

 

Empower your strategic planning

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the anti-venom market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 20 Companies Leading the Iron-Deficiency Anemia Treatment Market

1. Sanofi
2. AbbVie Inc.
3. CSL Vifor
4. Pharmacosmos A/S
5. Akebia Therapeutics, Inc.
6. Daiichi Sankyo Company Limited
7. Johnson & Johnson Services, Inc.
8. Fresenius SE & Co. KGaA
9. Novartis AG
10. GlaxoSmithKline plc
11. Bayer AG
12. Pfizer Inc.
13. Teva Pharmaceutical Industries Ltd.
14. Zydus Lifesciences Limited
15. Lupin Limited
16. Apotex Inc.
17. AdvaCare Pharma
18. Shield Therapeutics plc
19. Rockwell Medical, Inc.
20. American Regent, Inc.

 

Unlock exclusive market insights— Download the Brochure now and dive deeper into the future of the Global Iron-Deficiency Anemia Treatment Market

1.Sanofi
Headquarters: Paris, France

It is a multinational pharmaceutical company based in France, established in 1973, with revenues in the tens of billions in 2024, offering a balanced product range including both oral, e.g., Maltofer, and intravenous iron products, as well as a range of other drugs, and is known for its strong infrastructure in research and development, as well as global distribution, in the chronic and acute care markets.

 

2.AbbVie Inc.
Headquarters: North Chicago, Illinois

AbbVie Inc., founded in 2013, is a large biopharmaceutical company based in the US, with revenues in the tens of billions, primarily known for a range of drugs, including in the immunology and oncology categories, but while the company’s iron deficiency anemia product range is smaller compared to the flagship products, the company has a global footprint in over 170 countries, with operations in the US, Europe, Asia, Latin America, etc.

 

3.CSL Vifor
Headquarters: St. Gallen, Switzerland

CSL Vifor, tracing its roots back to 1927 and now part of the CSL group as CSL Limited, is a Swiss-based specialty pharmaceutical leader with an intense focus on iron deficiency therapies, driving substantial revenue in the iron deficiency therapy segment (approximately $1.2 billion in 2024 for its IDA therapy portfolio), with major brands such as its Ferinject/Injectafer (ferric carboxymaltose) and Venofer (iron sucrose) drugs, and is active in over 100 countries with its headquarters in St. Gallen, Switzerland, and significant market shares in IV and oral iron replacement therapy.

 

4.Pharmacosmos A/S
Headquarters: Holbaek, Denmark

Pharmacosmos A/S, founded in 1965, is a Denmark-based pharmaceutical specialist solely focused on iron deficiency anemia therapy, with major brands such as Monofer and Cosmofer, and development, production, and research facilities in Holbæk, Denmark, and commercial operations in Europe, the U.S., and Asia, often through partnerships, and is known for its R&D pipeline focused on iron replacement therapy.

 

5.Daiichi Sankyo Company, Limited
Headquarters: Tokyo, Japan

Daiichi Sankyo Company, Limited, established in 2005 with its origin through reorganization of Sankyo, is a global pharmaceutical company based in Japan with revenues of almost a billion USD in iron deficiency anemia treatments, including oral and injectable iron products like Injectafer in Japan and Tardyferon, operating globally with facilities in Asia, Europe, and America, utilizing its strong regional ties to expand its reach and reduce regulatory hurdles.

 

Are you ready to discover more about the Iron-Deficiency Anemia Treatment Market?

The report provides an in-depth analysis of the leading companies operating in the global iron-deficiency anemia treatment market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardised format that includes:

 

Company Profile

1. Sanofi

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

1. AbbVie Inc.
2. CSL Vifor
3. Pharmacosmos A/S
4. Akebia Therapeutics, Inc.
5. Daiichi Sankyo Company Limited
6. Johnson & Johnson Services, Inc.
7. Fresenius SE & Co. KGaA
8. Novartis AG
9. GlaxoSmithKline plc
10. Bayer AG
11. Pfizer Inc.
12. Teva Pharmaceutical Industries Ltd.
13. Zydus Lifesciences Limited
14. Lupin Limited
15. Apotex Inc.
16. AdvaCare Pharma
17. Shield Therapeutics plc
18. Rockwell Medical, Inc.
19. American Regent, Inc.

 

Unlock exclusive market insights— Download the Brochure now and dive deeper into the future of the Global Iron-Deficiency Anemia Treatment Market

Conclusion

The Global Iron-Deficiency Anemia Treatment Market size is expected to grow at a compound annual growth rate (CAGR) of 6.9%, from USD 5.47 billion in 2024 to USD 11.37 billion by 2035.  Global market expansion is fuelled by rising prevalence of iron-deficiency anemia (especially among women and children), growing awareness and screening programs, improving access to healthcare, and rising adoption of advanced therapies. North America held the majority of the market share by revenue due to its established healthcare system, awareness among the population and access to modern diagnostic tools and treatment methods. Asia-Pacific is projected to grow the fastest during the forecast period due to the government health programs, increased healthcare funding, and a better understanding of the benefits of early disease detection and treatment.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter